{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:48:18Z","timestamp":1794001698451,"version":"4.8.0"},"reference-count":76,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Rosacea is a chronic inflammatory cutaneous disorder predominantly affecting the centrofacial region, whose pathogenesis is complex and not yet fully understood. In this review we summarized the latest significant advances in the pathogenesis of rosacea in recent years. In genomic studies, the application of bioinformatics techniques such as whole-genome sequencing has identified novel susceptibility genes and linked multiple pathogenic mechanisms. Neurovascular dysfunction resulting from abnormal neuropeptides expression and dysregulated amino acid metabolism constitutes an important pathogenic factor in rosacea. The TLR2\/LL-37\/mTORC1 signaling axis, as a core regulatory pathway in innate immunity has been elucidated in detail. In addition, the dysbiosis of skin and gut microbiota, together with the impairment of skin barrier function, is also closely associated with the onset and progression of this disease. The deeper understanding of the pathogenesis of rosacea will benefit the development of new drugs and promote individualized diagnosis and treatment.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1705588","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:51:16Z","timestamp":1768978276000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Advances in the pathogenesis of rosacea"],"prefix":"10.3389","volume":"16","author":[{"given":"Hui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcp1506630","article-title":"Rosacea","volume":"377","author":"Van Zuuren","year":"2017","journal-title":"New Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.05.113","article-title":"Red scrotum syndrome: An update on clinicopathologic features, pathogenesis, diagnosis, and management","volume":"87","author":"Khalil","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16481","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.12.038","article-title":"Epidemiology of acne and rosacea: A worldwide global study","volume":"90","author":"Saurat","year":"2024","journal-title":"J Am Acad Dermatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S390921","article-title":"A cross-sectional study on the relationship between rosacea severity and quality of life or psychological state","volume":"15","author":"Yang","year":"2022","journal-title":"Clinical Cosmetic Investigational Dermatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13748","article-title":"Feelings of stigmatization in patients with rosacea","volume":"31","author":"Halioua","year":"2017","journal-title":"J Eur Acad Dermatol Venereology: JEADV"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.18420","article-title":"Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel","volume":"182","author":"Schaller","year":"2020","journal-title":"Br J Dermatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1177\/12034754241229365","article-title":"Rosacea: pathogenesis and therapeutic correlates","volume":"28","author":"Geng","year":"2024","journal-title":"J Cutan Med Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14849","article-title":"S2k guideline: rosacea","volume":"20","author":"Clanner-Engelshofen","year":"2022","journal-title":"J Dtsch Dermatol Ges"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2015.2230","article-title":"Genetic vs environmental factors that correlate with rosacea: A cohort-based survey of twins","volume":"151","author":"Aldrich","year":"2015","journal-title":"JAMA Dermatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2022.2077427","article-title":"Mediation roles of neutrophils and high-density lipoprotein (HDL) on the relationship between HLA-DQB1 and rosacea","volume":"54","author":"Xiao","year":"2022","journal-title":"Ann Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.53","article-title":"Assessment of the genetic basis of rosacea by genome-wide association study","volume":"135","author":"Chang","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16241","article-title":"Rosacea as a striking feature in family members with a STAT1 gain-of-function mutation","volume":"34","author":"S\u00e1ez-De-Ocariz","year":"2020","journal-title":"J Eur Acad Dermatol Venereology: JEADV"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.760019","article-title":"Case report: A new gain-of-function mutation of STAT1 identified in a patient with chronic mucocutaneous candidiasis and rosacea-like demodicosis: an emerging association","volume":"12","author":"Martinot","year":"2021","journal-title":"Front In Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14413","article-title":"Rosacea and demodicidosis associated with gain-of-function mutation in STAT1","volume":"31","author":"Second","year":"2017","journal-title":"J Eur Acad Dermatol Venereology: JEADV"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.674871","article-title":"Keratinocyte-immune cell crosstalk in a STAT1-mediated pathway: novel insights into rosacea pathogenesis","volume":"12","author":"Deng","year":"2021","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2006.00220.x","article-title":"GSTM1 and GSTT1 null genotypes as possible herit able factors of rosacea","volume":"22","author":"Yazici","year":"2006","journal-title":"Photodermatology Photoimmunology Photomedicine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2019.09.021","article-title":"Alterations of immune and keratinization gene expression in papulopustular rosacea by whole transcriptome analysis","volume":"140","author":"Shih","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/ced.13769","article-title":"Role of serum 25-hydroxyvitamin D levels and vitamin D receptor gene polymorphisms in patients with rosacea: a case-control study","volume":"44","author":"Akdogan","year":"2019","journal-title":"Clin Exp Dermatol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/nu15173803","article-title":"Vitamin D status, vitamin D receptor polymorphisms, and the risk of incident rosacea: insights from mendelian randomization and cohort study in the UK biobank","volume":"15","author":"Mao","year":"2023","journal-title":"Nutrients"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1038\/s41467-023-39761-2","article-title":"Whole genome sequencing identifies genetic variants associated with neurogenic inflammation in rosacea","volume":"14","author":"Deng","year":"2023","journal-title":"Nat Commun"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.424","article-title":"Distribution and expression of non-neuronal transient receptor potential (TRPV) ion channels in rosacea","volume":"132","author":"Sulk","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/ph9040077","article-title":"TRP channels in skin biology and pathophysiology","volume":"9","author":"Caterina","year":"2016","journal-title":"Pharm (Basel)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47746","article-title":"Regulatory switch at the cytoplasmic interface controls TRPV channel gating","volume":"8","author":"Zubcevic","year":"2019","journal-title":"ELife"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-018-0675-z","article-title":"Skin neurogenic inflammation","volume":"40","author":"Choi","year":"2018","journal-title":"Semin Immunopathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24055001","article-title":"Molecular mechanisms of neurogenic inflammation of the skin","volume":"24","author":"Marek-Jozefowicz","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.161870","article-title":"Aberrant amino acid metabolism promotes neurovascular reactivity in rosacea","volume":"7","author":"Liu","year":"2022","journal-title":"JCI Insight"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13314","article-title":"Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases","volume":"26","author":"Niyonsaba","year":"2017","journal-title":"Exp Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jdermsci.2015.12.006","article-title":"The role of altered cutaneous immune responses in the induction and persistence of rosacea","volume":"82","author":"Margalit","year":"2016","journal-title":"J Dermatol Sci"},{"key":"B30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.17179\/excli2020-3114","article-title":"Going, Toll-like receptors in skin inflammation and inflammatory diseases","volume":"20","author":"Kumar","year":"2021","journal-title":"Excli J"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.3.1535","article-title":"Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses","volume":"169","author":"Kim","year":"2002","journal-title":"J Immunol (Baltimore Md.: 1950)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.351","article-title":"TLR2 expression is increased in rosacea and stimulates enhanced serine protease production by keratinocytes","volume":"131","author":"Yamasaki","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jid.2019.08.434","article-title":"Superoxide dismutase 3 inhibits LL-37\/KLK-5-mediated skin inflammation through modulation of EGFR and associated inflammatory cascades","volume":"140","author":"Agrahari","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2014.09.002","article-title":"Cathelicidin peptide LL-37 increases UVB-triggered inflammasome activation: possible implications for rosacea","volume":"76","author":"Salzer","year":"2014","journal-title":"J Dermatol Sci"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45040177","article-title":"Long-term administration of LL-37 can induce irreversible rosacea-like lesion","volume":"45","author":"Zhang","year":"2023","journal-title":"Curr Issues In Mol Biol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"113292","DOI":"10.1016\/j.biopha.2022.113292","article-title":"Celastrol inhibits LL37-induced rosacea by inhibiting Ca(2+)\/CaMKII-mTOR-NF-\u03baB activation","volume":"153","author":"Zeng","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202013560","article-title":"A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea","volume":"13","author":"Deng","year":"2021","journal-title":"EMBO Mol Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S393122","article-title":"Thalidomide attenuates skin lesions and inflammation in rosacea-like mice induced by long-term exposure of LL-37","volume":"16","author":"Kang","year":"2022","journal-title":"Drug Design Dev Ther"},{"key":"B39","doi-asserted-by":"publisher","first-page":"155444","DOI":"10.1016\/j.cyto.2021.155444","article-title":"Identification of novel candidate genes in rosacea by bioinformatic methods","volume":"141","author":"Sun","year":"2021","journal-title":"Cytokine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13143","article-title":"Integrative concepts of rosacea pathophysiology, clinical presentation and new therapeutics","volume":"26","author":"Holmes","year":"2017","journal-title":"Exp Dermatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.02.745","article-title":"Antimicrobial peptide LL-37 drives rosacea-like skin inflammation in an NLRP3-dependent manner","volume":"141","author":"Yoon","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"110057","DOI":"10.1016\/j.intimp.2023.110057","article-title":"Supramolecular salicylic acid ameliorates rosacea-like eruptions by suppressing NLRP3-mediated inflammasome activation in mice","volume":"118","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2021.04.024","article-title":"Cathelicidin LL-37 ignites primed NLRP3 inflammasomes in rosacea","volume":"141","author":"Croitoru","year":"2021","journal-title":"J Invest Dermatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.222","article-title":"Mast cells are key mediators of cathelicidin-initiated skin inflammation in rosacea","volume":"134","author":"Muto","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-007-0816-z","article-title":"A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process","volume":"300","author":"Aroni","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2015.141","article-title":"Molecular and morphological characterization of inflammatory infiltrate in rosacea reveals activation of th1\/th17 pathways","volume":"135","author":"Buhl","year":"2015","journal-title":"J Invest Dermatol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26030927","article-title":"Mast cells at the crossroads of hypersensitivity reactions and neurogenic inflammation","volume":"26","author":"Aitella","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4HI1018-390R","article-title":"Frontline Science: Mast cells regulate neutrophil homeostasis by influencing macrophage clearance activity","volume":"105","author":"Jachetti","year":"2019","journal-title":"J Leukoc Biol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2988","DOI":"10.1016\/j.jid.2022.05.005","article-title":"Role of mrgprB2 in rosacea-like inflammation in mice: modulation by \u03b2-arrestin 2","volume":"142","author":"Roy","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13381","article-title":"Inhibition of mast cell infiltration in an LL-37-induced rosacea mouse model using topical brimonidine tartrate 0.33% gel","volume":"26","author":"Kim","year":"2017","journal-title":"Exp Dermatol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2019.00324","article-title":"The theranostics role of mast cells in the pathophysiology of rosacea","volume":"6","author":"Wang","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.IJD_18_20","article-title":"Immunohistochemical analysis of differences of toll-like receptor 2, mast cells, and neurofilaments between granulomatous rosacea and non-granulomatous rosacea","volume":"66","author":"Jang","year":"2021","journal-title":"Indian J Dermatol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2018.12.031","article-title":"Tranexamic acid ameliorates rosacea symptoms through regulating immune response and angiogenesis","volume":"67","author":"Li","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248650","article-title":"Elucidating the immune infiltration in acne and its comparison with rosacea by integrated bioinformatics analysis","volume":"16","author":"Yang","year":"2021","journal-title":"PloS One"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14169","article-title":"Serum IL-17 levels in patients with rosacea","volume":"21","author":"Hayran","year":"2022","journal-title":"J Cosmet Dermatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.01.892","article-title":"Comparative analysis of rosacea and cutaneous lupus erythematosus: histopathologic features, T-cell subsets, and plasmacytoid dendritic cells","volume":"71","author":"Brown","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.86207","article-title":"Targeting aquaporin-3 attenuates skin inflammation in rosacea","volume":"19","author":"Chen","year":"2023","journal-title":"Int J Biol Sci"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12121","article-title":"Rosacea under the microscope: characteristic histological findings","volume":"27","author":"Cribier","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5114\/pdia.2013.33372","article-title":"Antinuclear antibodies in rosacea patients","volume":"30","author":"Wo\u017aniacka","year":"2013","journal-title":"Postepy Dermatol Alergol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2020.02.025","article-title":"Rosacea is characterized by a profoundly diminished skin barrier","volume":"140","author":"Medgyesi","year":"2020","journal-title":"J Invest Dermatol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"Sf3595563","DOI":"10.36849\/JDD.m0922","article-title":"Supplement article: skin barrier deficiency in rosacea: an algorithm integrating OTC skincare products into treatment regimens","volume":"21","author":"Baldwin","year":"2022","journal-title":"J Drugs Dermatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S356551","article-title":"Multi-transcriptomic analysis and experimental validation implicate a central role of STAT3 in skin barrier dysfunction induced aggravation of rosacea","volume":"15","author":"Wang","year":"2022","journal-title":"J Inflammation Res"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14792","article-title":"Claudin reduction may relate to an impaired skin barrier in rosacea","volume":"46","author":"Deng","year":"2019","journal-title":"J Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8737","DOI":"10.1038\/s41467-024-52946-7","article-title":"Single-cell transcriptomics reveals aberrant skin-resident cell populations and identifies fibroblasts as a determinant in rosacea","volume":"15","author":"Chen","year":"2024","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.03.040","article-title":"Role of Demodex mite infestation in rosacea: A systematic review and meta-analysis","volume":"77","author":"Chang","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00458-9","article-title":"The pathogenic role of demodex mites in rosacea: A potential therapeutic target already in erythematotelangiectatic rosacea","volume":"10","author":"Forton","year":"2020","journal-title":"Dermatol Ther"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.16540","article-title":"Demodex mites modulate sebocyte immune reaction: possible role in the pathogenesis of rosacea","volume":"179","author":"Lacey","year":"2018","journal-title":"Br J Dermatol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.19315","article-title":"Bacterial and fungal microbiome characterization in patients with rosacea and healthy controls","volume":"183","author":"Wang","year":"2020","journal-title":"Br J Dermatol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010185","article-title":"Characterization and analysis of the skin microbiota in rosacea: impact of systemic antibiotics","volume":"9","author":"Woo","year":"2020","journal-title":"J Clin Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00471-5","article-title":"Characterization and analysis of the skin microbiota in rosacea: A case-control study","volume":"21","author":"Rainer","year":"2020","journal-title":"Am J Clin Dermatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.03.031","article-title":"Microbe-host interaction in rosacea and its modulation through topical ivermectin","volume":"145","author":"Olah","year":"2025","journal-title":"J Invest Dermatol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.08.006","article-title":"Potential role of microorganisms in the pathogenesis of rosacea","volume":"69","author":"Holmes","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201600008","article-title":"The gut-skin axis in health and disease: A paradigm with therapeutic implications","volume":"38","author":"O\u2019neill","year":"2016","journal-title":"BioEssays: News Rev In Molecular Cell Dev Biol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.14231","article-title":"Investigating causal relationships between the gut microbiota and inflammatory skin diseases: A Mendelian randomization study","volume":"65","author":"Gu","year":"2024","journal-title":"Australas J Dermatol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1322685","article-title":"Causal relationship between gut microbiota and rosacea: a two-sample Mendelian randomization study","volume":"11","author":"Li","year":"2024","journal-title":"Front Med (Lausanne)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1297240","article-title":"The associations between gut microbiota and inflammatory skin diseases: a bi-directional two-sample Mendelian randomization study","volume":"15","author":"Zhong","year":"2024","journal-title":"Front In Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1705588\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T06:51:17Z","timestamp":1768978277000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1705588\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":76,"alternative-id":["10.3389\/fimmu.2025.1705588"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1705588","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"article-number":"1705588"}}